Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (DE:LLY)
XETRA:LLY
Eli Lilly & Co (LLY) Stock Forecast & Price Target
87 Followers
See the Price Targets and Ratings of:
LLY Analyst Ratings
Strong Buy
17 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LLY Stock 12 Month Forecast
Average Price Target
€851.88
▼(-2.24% Downside)
| Highest Price Target€1,010 | Average Price Target€851.88 | Lowest Price Target€665.73 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Morgan Stanley
Reiterated
07/11/24
J.P. Morgan
Reiterated
07/11/24
Barclays
Reiterated
07/10/24
Berenberg Bank
Reiterated
07/10/24
Goldman Sachs
Reiterated
07/08/24
Wells Fargo
Reiterated
07/08/24
BMO Capital
Reiterated
07/08/24
Deutsche Numis
Reiterated
07/08/24
Evercore ISI
Assigned
07/03/24
Truist Financial
―
Buy
―
Reiterated
07/03/24
Eli Lilly & Co (LLY) Receives a Buy from Truist Financial
Jefferies
€932.02→€955.9
Buy
9.70%
Upside
Reiterated
07/02/24
Eli Lilly's Promising Alzheimer's Treatment: A Buy Rating on Kisunla's Market Potential and Clinical Benefits
Cantor Fitzgerald
€812.65
Buy
-6.74%
Downside
Reiterated
07/01/24
Cantor Fitzgerald Sticks to Its Buy Rating for Eli Lilly & Co (LLY)
Bank of America Securities
€918.25
Buy
5.38%
Upside
Reiterated
06/26/24
Buy Rating Affirmed for Eli Lilly on Tirzepatide's Promise in OSA and Obesity Treatment
TD Cowen
€780.51
Buy
-10.43%
Downside
Reiterated
06/13/24
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (NYSE: LLY) and Cardinal Health (NYSE: CAH)
Best Analysts Covering Eli Lilly & Co
Which Analyst Should I Follow If I Want to Buy DE:LLY and Sell After:
1 Month
xxx
Success Rate
14/15 ratings generated profit
Average Return
+8.88%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 93.33% of your transactions generating a profit, with an average return of +8.88% per trade.
3 Months
xxx
Success Rate
15/15 ratings generated profit
Average Return
+17.88%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +17.88% per trade.
1 Year
Success Rate
28/28 ratings generated profit
Average Return
+62.22%
reiterated a buy rating 6 days ago
Copying Terence Flynn's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +62.22% per trade.
2 Years
xxx
Success Rate
15/15 ratings generated profit
Average Return
+121.77%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +121.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LLY Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
0
0
0
0
0
Buy
68
75
63
62
53
Hold
6
6
6
5
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
74
81
69
67
62
Each month's total comprises the sum of three months' worth of ratings.
LLY Financial Forecast
LLY Stock Forecast FAQ
What is DE:LLY’s average 12-month price target, according to analysts?
Based on analyst ratings, Eli Lilly & Co’s 12-month average price target is €851.88.
What is DE:LLY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:LLY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Eli Lilly & Co a Buy, Sell or Hold?
Eli Lilly & Co has a consensus rating of Strong Buy, which is based on 17 buy ratings, 4 hold ratings and 0 sell ratings.
What is Eli Lilly & Co’s share price target?
The average share price target for Eli Lilly & Co is €851.88. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €1,010.08 ,and the lowest forecast is €665.73. The average share price target represents -2.24% Decrease from the current price of €871.4.
The highest analyst share price target is €1,010.08 ,and the lowest forecast is €665.73. The average share price target represents -2.24% Decrease from the current price of €871.4.
What do analysts say about Eli Lilly & Co?
Eli Lilly & Co’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.
How can I buy shares of Eli Lilly & Co?
To buy shares of DE:LLY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.